Oestrogen activity of the serum in adolescents with Type 1 diabetes
Author
dc.contributor.author
Martínez, D.
Author
dc.contributor.author
Castro, A.
Author
dc.contributor.author
Merino Osorio, Paulina
Author
dc.contributor.author
López, P.
Author
dc.contributor.author
Lardone, María Cecilia
Author
dc.contributor.author
Iñíguez Vila, Germán
Author
dc.contributor.author
Cassorla Goluboff, Fernando
Author
dc.contributor.author
Codner Dujovne, Ethel
Admission date
dc.date.accessioned
2017-03-06T16:34:54Z
Available date
dc.date.available
2017-03-06T16:34:54Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Diabetic Medicine. Volumen: 33 Número: 10 Páginas: 1366-1373 Número especial: SI
es_ES
Identifier
dc.identifier.other
10.1111/dme.13078
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/143003
Abstract
dc.description.abstract
AimsTo assess serum oestrogen levels and oestrogenic activity in adolescents with Type 1 diabetes compared with a healthy control group.
MethodsWe conducted a cross-sectional study that evaluated adolescents with Type 1 diabetes (n = 38) and healthy adolescents (control group; n = 32). Serum oestrogens, urinary oestrogen metabolites and serum oestrogenic activity were assessed. Oestrogenic activity was evaluated in an in vitro cell proliferation assay using a modified E-screen assay with MCF-7/BUS cells.
ResultsAdolescents with Type 1 diabetes had lower oestrogenic activity levels in both phases of the menstrual cycle compared with the control group (follicular phase: 76 vs 94%; luteal phase: 97 vs 131%; P < 0.01), even after adjusting for BMI, oestradiol and oestrone levels. Postmenarcheal adolescents with Type 1 diabetes had lower oestradiol levels compared with control subjects in the follicular phase (63.3 pmol/l vs 89.4 pmol/l; P < 0.01) and higher oestrone levels compared with controls in the luteal phase (196 vs 151.9 pmol/l; P < 0.05).
ConclusionsAdolescents with Type 1 diabetes had lower levels of serum oestrogenic activity, and these were lower than expected based on their serum oestradiol levels. We postulate that changes in the serum milieu of oestrogens in patients with Type 1 diabetes may explain their decreased oestrogenic activity and may play a role in their adverse metabolic profile.